{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:54:37Z","timestamp":1788317677999,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Phayao and Thailand Science Research and Innovation Fund","award":["Fundamental Fund 2025 (5044\/2567)"],"award-info":[{"award-number":["Fundamental Fund 2025 (5044\/2567)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"DOI":"10.1007\/s41999-025-01398-3","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:24:46Z","timestamp":1768296286000},"page":"589-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antidementia drugs and nursing home placement: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"17","author":[{"given":"Pitchayut","family":"Rattanatanyapat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratchaya","family":"Suan-ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Saokaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pochamana","family":"Phisalprapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-1557","authenticated-orcid":false,"given":"Pajaree","family":"Mongkhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"1398_CR1","unstructured":"World Health Organization (2017) Global action plan on the public health response to dementia 2017\u20132025. [cited 2024 17th March]; Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/259615\/9789241513487-eng.pdf?sequence=1."},{"issue":"3","key":"1398_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7(3):263\u2013269","journal-title":"Alzheimers Dement"},{"key":"1398_CR3","unstructured":"Prince M, Wimo A., Guerchet M, Ali GC, Wu YT, Prina M (2015) World Alzheimer report 2015: the global impact of dementia - an analysis of prevalence, incidence, cost and trends. London: Alzheimer\u2019s Disease International (ADI)"},{"issue":"3","key":"1398_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1532-5415.2004.52118.x","volume":"52","author":"AJ Bharucha","year":"2004","unstructured":"Bharucha AJ et al (2004) Predictors of nursing facility admission: a 12-year epidemiological study in the United States. J Am Geriatr Soc 52(3):434\u2013439","journal-title":"J Am Geriatr Soc"},{"issue":"16","key":"1398_CR5","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1001\/jama.287.16.2090","volume":"287","author":"K Yaffe","year":"2002","unstructured":"Yaffe K et al (2002) Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 287(16):2090\u20132097","journal-title":"JAMA"},{"issue":"1","key":"1398_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/geront\/gnq050","volume":"51","author":"C Wattmo","year":"2011","unstructured":"Wattmo C et al (2011) Risk factors for nursing home placement in Alzheimer\u2019s disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. Gerontologist 51(1):17\u201327","journal-title":"Gerontologist"},{"issue":"2","key":"1398_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610216001654","volume":"29","author":"S Toot","year":"2017","unstructured":"Toot S et al (2017) Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis. Int Psychogeriatr 29(2):195\u2013208","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"1398_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/jamainternmed.2023.8522","volume":"184","author":"DB Reuben","year":"2024","unstructured":"Reuben DB, Kremen S, Maust DT (2024) Dementia prevention and treatment: a narrative review. JAMA Intern Med 184(5):563\u2013572","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1398_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B et al (2016) Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol 15(5):455\u2013532","journal-title":"Lancet Neurol"},{"issue":"3-4","key":"1398_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000486546","volume":"45","author":"R Knight","year":"2018","unstructured":"Knight R et al (2018) A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord 45(3\u20134):131\u2013151","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"1398_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1192\/bjp.2020.136","volume":"218","author":"N Vaci","year":"2021","unstructured":"Vaci N et al (2021) Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study. Br J Psychiatry 218(5):261\u2013267","journal-title":"Br J Psychiatry"},{"issue":"9427","key":"1398_CR12","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(04)16499-4","volume":"363","author":"C Courtney","year":"2004","unstructured":"Courtney C et al (2004) Long-term donepezil treatment in 565 patients with Alzheimer\u2019s disease (AD2000): randomised double-blind trial. Lancet 363(9427):2105\u20132115","journal-title":"Lancet"},{"key":"1398_CR13","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1017\/S2045796019000702","volume":"29","author":"T M\u00f6llers","year":"2020","unstructured":"M\u00f6llers T et al (2020) Alzheimer\u2019s disease medication and outcomes of hospitalisation among patients with dementia. Epidemiol Psychiatr Sci 29:e73","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"10","key":"1398_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1192\/pb.bp.110.033431","volume":"35","author":"E Salib","year":"2011","unstructured":"Salib E, Thompson J (2011) Use of anti-dementia drugs and delayed care home placement: an observational study. Psychiatr 35(10):384\u2013388","journal-title":"Psychiatr"},{"issue":"3","key":"1398_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00002093-200607000-00005","volume":"20","author":"M Becker","year":"2006","unstructured":"Becker M et al (2006) The effect of cholinesterase inhibitors on risk of nursing home placement among medicaid beneficiaries with dementia. Alzheimer Dis Assoc Disord 20(3):147\u2013152","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"1398_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jnnp.2008.158964","volume":"80","author":"OL Lopez","year":"2009","unstructured":"Lopez OL et al (2009) Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. J Neurol Neurosurg Psychiatry 80(6):600\u2013607","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1398_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"3","key":"1398_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2014.12.013","volume":"16","author":"AM Sanford","year":"2015","unstructured":"Sanford AM et al (2015) An international definition for \u201cnursing home.\u201d J Am Med Dir Assoc 16(3):181\u2013184","journal-title":"J Am Med Dir Assoc"},{"key":"1398_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"1398_CR20","unstructured":"Wells GA et al. (2014) The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomised studies in meta-analyses"},{"issue":"4","key":"1398_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H et al (2011) GRADE guidelines: 3 rating the quality of evidence. J Clin Epidemiol 64(4):401\u2013406","journal-title":"J Clin Epidemiol"},{"key":"1398_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.socscimed.2017.05.049","volume":"186","author":"E Shor","year":"2017","unstructured":"Shor E, Roelfs D, Vang ZM (2017) The \u201cHispanic mortality paradox\u201d revisited: meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants\u2019 mortality. Soc Sci Med 186:20\u201333","journal-title":"Soc Sci Med"},{"issue":"19","key":"1398_CR23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF (1998) What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280(19):1690\u20131691","journal-title":"JAMA"},{"issue":"1","key":"1398_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40264-024-01476-8","volume":"48","author":"P Mongkhon","year":"2025","unstructured":"Mongkhon P et al (2025) Comparative effectiveness and safety of off-label underdosed direct oral anticoagulants in Asian patients with atrial fibrillation: a systematic review and meta-analysis. Drug Saf 48(1):25\u201342","journal-title":"Drug Saf"},{"issue":"3","key":"1398_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"2","key":"1398_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M et al (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111","journal-title":"Res Synth Methods"},{"issue":"7414","key":"1398_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"15","key":"1398_CR28","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2165\/00023210-200418150-00008","volume":"18","author":"KM Beusterien","year":"2004","unstructured":"Beusterien KM et al (2004) Impact of rivastigmine use on the risk of nursing home placement in a US sample. CNS Drugs 18(15):1143\u20131148","journal-title":"CNS Drugs"},{"issue":"1","key":"1398_CR29","first-page":"166","volume":"47","author":"D Knopman","year":"1996","unstructured":"Knopman D et al (1996) Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality. Tacrine Study Group Neurol 47(1):166\u2013177","journal-title":"Tacrine Study Group Neurol"},{"issue":"12","key":"1398_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1474-4422(15)00258-6","volume":"14","author":"R Howard","year":"2015","unstructured":"Howard R et al (2015) Nursing home placement in the donepezil and memantine in moderate to severe Alzheimer\u2019s disease (DOMINO-AD) trial: secondary and post-hoc analyses. Lancet Neurol 14(12):1171\u20131181","journal-title":"Lancet Neurol"},{"issue":"7","key":"1398_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1046\/j.1365-2389.2003.51306.x","volume":"51","author":"DS Geldmacher","year":"2003","unstructured":"Geldmacher DS et al (2003) Donepezil is associated with delayed nursing home placement in patients with Alzheimer\u2019s disease. J Am Geriatr Soc 51(7):937\u2013944","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1398_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/gps.4015","volume":"29","author":"A Rongve","year":"2014","unstructured":"Rongve A et al (2014) Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer\u2019s dementia. Int J Geriatr Psychiatry 29(4):392\u2013398","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"1398_CR33","doi-asserted-by":"publisher","first-page":"e190213","DOI":"10.1001\/jamanetworkopen.2019.0213","volume":"2","author":"A San-Juan-Rodriguez","year":"2019","unstructured":"San-Juan-Rodriguez A et al (2019) Association of antidementia therapies with time to skilled nursing facility admission and cardiovascular events among elderly adults with Alzheimer disease. JAMA Netw Open 2(3):e190213","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1398_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3111\/13696990903004039","volume":"12","author":"HT Hatoum","year":"2009","unstructured":"Hatoum HT et al (2009) Predicting time to nursing home placement based on activities of daily living scores\u2014a modelling analysis using data on Alzheimer\u2019s disease patients receiving rivastigmine or donepezil. J Med Econ 12(2):98\u2013103","journal-title":"J Med Econ"},{"issue":"6","key":"1398_CR35","first-page":"Cd001190","volume":"6","author":"JS Birks","year":"2018","unstructured":"Birks JS, Harvey RJ (2018) Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev 6(6):Cd001190","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1398_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-132690","volume":"41","author":"CC Tan","year":"2014","unstructured":"Tan CC et al (2014) Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 41(2):615\u2013631","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"1398_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","volume":"366","author":"R Howard","year":"2012","unstructured":"Howard R et al (2012) Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 366(10):893\u2013903","journal-title":"N Engl J Med"},{"issue":"1","key":"1398_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","volume":"10","author":"KX Dou","year":"2018","unstructured":"Dou KX et al (2018) Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials. Alzheimers Res Ther 10(1):126","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1398_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cpt.1104","volume":"105","author":"KK Tsoi","year":"2019","unstructured":"Tsoi KK et al (2019) Monotherapy is good enough for patients with mild-to-moderate Alzheimer\u2019s disease: a network meta-analysis of 76 randomized controlled trials. Clin Pharmacol Ther 105(1):121\u2013130","journal-title":"Clin Pharmacol Ther"},{"key":"1398_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jpurol.2024.11.021","volume":"21","author":"LH Braga","year":"2024","unstructured":"Braga LH et al (2024) Randomized controlled trials \u2013 the what, when, how and why. J Pediatr Urol 21:397","journal-title":"J Pediatr Urol"},{"issue":"3","key":"1398_CR41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3233\/JAD-230878","volume":"98","author":"BM Cesana","year":"2024","unstructured":"Cesana BM et al (2024) Predictors of nursing home placement in a cohort of European people with Alzheimer\u2019s disease and other dementia cases enrolled in SCU-B or non SCU-B centers: the RECage study. J Alzheimers Dis 98(3):1043\u20131052","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1398_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0898264307299359","volume":"19","author":"R Andel","year":"2007","unstructured":"Andel R, Hyer K, Slack A (2007) Risk factors for nursing home placement in older adults with and without dementia. J Aging Health 19(2):213\u2013228","journal-title":"J Aging Health"},{"issue":"2","key":"1398_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/geront\/43.2.219","volume":"43","author":"JE Gaugler","year":"2003","unstructured":"Gaugler JE et al (2003) Caregiving and institutionalization of cognitively impaired older people: utilizing dynamic predictors of change. Gerontologist 43(2):219\u2013229","journal-title":"Gerontologist"},{"issue":"3","key":"1398_CR44","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/jgs.17579","volume":"70","author":"PP Masurkar","year":"2022","unstructured":"Masurkar PP et al (2022) Risk of overactive bladder associated with cholinesterase inhibitors in dementia. J Am Geriatr Soc 70(3):820\u2013830","journal-title":"J Am Geriatr Soc"},{"key":"1398_CR45","doi-asserted-by":"publisher","first-page":"105629","DOI":"10.1016\/j.archger.2024.105629","volume":"128","author":"SG Chikermane","year":"2025","unstructured":"Chikermane SG, Li J, Aparasu RR (2025) Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer\u2019s disease. Arch Gerontol Geriatr 128:105629","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"1398_CR46","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3233\/JAD-201502","volume":"81","author":"O Halminen","year":"2021","unstructured":"Halminen O et al (2021) Early start of anti-dementia medication delays transition to 24-hour care in Alzheimer\u2019s disease patients: a Finnish nationwide cohort study. J Alzheimers Dis 81(3):1103\u20131115","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1398_CR47","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10198-022-01553-8","volume":"24","author":"A Vesikansa","year":"2023","unstructured":"Vesikansa A et al (2023) Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer\u2019s patients: a Finnish nationwide register study. Eur J Health Econ 24(9):1421\u20131428","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1398_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12877-020-1452-0","volume":"20","author":"MMD de Medeiros","year":"2020","unstructured":"de Medeiros MMD et al (2020) Does the institutionalization influence elderly\u2019s quality of life? A systematic review and meta-analysis. BMC Geriatr 20(1):44","journal-title":"BMC Geriatr"},{"issue":"5","key":"1398_CR49","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/hsc.12984","volume":"28","author":"D-CA Lee","year":"2020","unstructured":"Lee D-CA, Tirlea L, Haines TP (2020) Non-pharmacological interventions to prevent hospital or nursing home admissions among community-dwelling older people with dementia: a systematic review and meta-analysis. Health Soc Care Community 28(5):1408\u20131429","journal-title":"Health Soc Care Community"},{"issue":"3","key":"1398_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2217\/cer.14.14","volume":"3","author":"MD Naylor","year":"2014","unstructured":"Naylor MD et al (2014) Comparison of evidence-based interventions on outcomes of hospitalized, cognitively impaired older adults. J Comp Eff Res 3(3):245\u2013257","journal-title":"J Comp Eff Res"},{"issue":"12","key":"1398_CR51","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/j.1532-5415.2009.02564.x","volume":"57","author":"U Eloniemi-Sulkava","year":"2009","unstructured":"Eloniemi-Sulkava U et al (2009) Family care as collaboration: effectiveness of a multicomponent support program for elderly couples with dementia. Randomized controlled intervention study. J Am Geriatr Soc 57(12):2200\u20132208","journal-title":"J Am Geriatr Soc"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01398-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:04:15Z","timestamp":1777021455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01398-3","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was evaluated by The Ethics Committee of the University of Phayao (UP-HEC 1.1\/012\/65) provided expedited approval for the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}